NCT03695588

Brief Summary

There is currently a gap in the literature with regards to the utility of the QLB performed in conjunction with intrathecal morphine (ITM) for Caesarean section. The aim of the study is to assess the efficacy of the QLB as part of a multi-modal analgesic approach in patients after caesarean section.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 4, 2018

Completed
26 days until next milestone

Study Start

First participant enrolled

October 30, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 24, 2019

Completed
Last Updated

July 23, 2019

Status Verified

July 1, 2019

Enrollment Period

6 months

First QC Date

October 1, 2018

Last Update Submit

July 22, 2019

Conditions

Keywords

pain reliefCaesareanCesareanc-sectionintrathecal morphineanalgesiaQLBQLQLB2QL2

Outcome Measures

Primary Outcomes (1)

  • IV PCA Morphine consumption up to 24 hours.

    Intravenous PCA (patient controlled analgesia) morphine consumption up to 24 hours.

    24 hours

Secondary Outcomes (7)

  • Pain scores at rest.

    6, 12, 24, 48 hours

  • Pain scores on movement.

    6, 12, 24, 48 hours

  • Nausea and vomiting.

    24, 48 hours

  • IV PCA morphine bolus demands.

    24 hours

  • Total opioid consumption at 48 hours.

    48 hours

  • +2 more secondary outcomes

Study Arms (2)

Quadratus lumborum block

ACTIVE COMPARATOR

Bilateral posterior QLB with 20ml 0.25% L-Bupivacaine.

Procedure: Quadratus lumborum block

Sham QLB

SHAM COMPARATOR

Sham QLB - Ultrasound identification of QLB followed by skin pressure with blunt needle. Patient blinded due to residual spinal anaesthetic block.

Procedure: Sham QLB

Interventions

Ultrasound guided Quadratus Lumborum block using a posterior approach. (QLB 2)

Quadratus lumborum block
Sham QLBPROCEDURE

Sham QLB - Ultrasound identification of QLB followed by skin pressure with blunt needle.

Sham QLB

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective Caesarean section under spinal anaesthesia.
  • Age \> 18 years old.
  • Singleton pregnancy.

You may not qualify if:

  • Contraindication to spinal or regional anaesthesia.
  • Allergy/sensitivity/contraindication to study medications.
  • Unable to comprehend visual analogue scale.
  • BMI \> 40.
  • Booking weight \<40kg.
  • History of chronic pain or regular opioid use.
  • Pre-eclampsia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Coombe Women and Infants University Hospital

Dublin, 00000, Ireland

Location

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Terry Tan

    Head of Department of Anaesthesia CWIUH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 1, 2018

First Posted

October 4, 2018

Study Start

October 30, 2018

Primary Completion

April 24, 2019

Study Completion

April 24, 2019

Last Updated

July 23, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations